These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31344599)

  • 1. Epidemiology of severe buprenorphine exposures reported to the U.S. Poison Centers.
    Rege SV; Ngo DA; Ait-Daoud N; Holstege CP
    Drug Alcohol Depend; 2019 Sep; 202():115-122. PubMed ID: 31344599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of pediatric buprenorphine and methadone exposures reported to the poison centers.
    Rege SV; Ngo DA; Ait-Daoud N; Rizer J; Sharma S; Holstege CP
    Ann Epidemiol; 2020 Feb; 42():50-57.e2. PubMed ID: 31992493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine Exposures Among Children and Adolescents Reported to US Poison Control Centers.
    Post S; Spiller HA; Casavant MJ; Chounthirath T; Smith GA
    Pediatrics; 2018 Jul; 142(1):. PubMed ID: 29941678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in gabapentin and baclofen exposures reported to U.S. poison centers.
    Reynolds K; Kaufman R; Korenoski A; Fennimore L; Shulman J; Lynch M
    Clin Toxicol (Phila); 2020 Jul; 58(7):763-772. PubMed ID: 31786961
    [No Abstract]   [Full Text] [Related]  

  • 5. Opioid Exposures Reported to U.S. Poison Centers.
    Rege SV; Smith M; Borek HA; Holstege CP
    Subst Use Misuse; 2021; 56(8):1169-1181. PubMed ID: 33939935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine exposures in adolescents and adults: a 10-year experience of a French Poison Control Center.
    Boulamery A; von Fabeck K; Glaizal M; de Haro L; Simon N
    Fundam Clin Pharmacol; 2021 Aug; 35(4):764-770. PubMed ID: 33174237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute poisoning in pregnancy: a province-wide perspective from a poison center.
    Zipursky JS; Yaphe H; Hudson H; Wong A; Thompson M
    Clin Toxicol (Phila); 2020 Jul; 58(7):736-741. PubMed ID: 31621422
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
    Kaland ME; Klein-Schwartz W
    Clin Toxicol (Phila); 2015 Jun; 53(5):477-85. PubMed ID: 25832473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intentional benzodiazepine poisoning in older adults reported to United States Poison Centers.
    Choi NG; Choi BY; Marti CN; Baker SD
    Clin Toxicol (Phila); 2024 Mar; 62(3):174-182. PubMed ID: 38683030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological trends in electronic cigarette exposures reported to U.S. Poison Centers.
    Vakkalanka JP; Hardison LS; Holstege CP
    Clin Toxicol (Phila); 2014 Jun; 52(5):542-8. PubMed ID: 24792781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected suicides and suicide attempts involving antipsychotic or sedative-hypnotic medications reported to America's Poison Centers, 2000-2021.
    Ybanez L; Spiller HA; Badeti J; Casavant MJ; Rine N; Michaels NL; Zhu M; Smith GA
    Clin Toxicol (Phila); 2023 Apr; 61(4):294-304. PubMed ID: 37010386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in intentional abuse or misuse of benzodiazepines and opioid analgesics and the associated mortality reported to poison centers across the United States from 2000 to 2014.
    Calcaterra SL; Severtson SG; Bau GE; Margolin ZR; Bucher-Bartelson B; Green JL; Dart RC
    Clin Toxicol (Phila); 2018 Nov; 56(11):1107-1114. PubMed ID: 29609498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory depression following medications for opioid use disorder (MOUD)-approved buprenorphine product oral exposures; National Poison Database System 2003-2019.
    Darracq MA; Thornton SL
    Clin Toxicol (Phila); 2021 Apr; 59(4):303-312. PubMed ID: 32894033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suicide attempts by self-poisoning in the United States among 10-25 year olds from 2000 to 2018: substances used, temporal changes and demographics.
    Spiller HA; Ackerman JP; Smith GA; Kistamgari S; Funk AR; McDermott MR; Casavant MJ
    Clin Toxicol (Phila); 2020 Jul; 58(7):676-687. PubMed ID: 31587583
    [No Abstract]   [Full Text] [Related]  

  • 15. Exposures in pregnant patients reported to United States Poison Centers.
    Leonard JB; Minhaj FS; Paterson E; Klein-Schwartz W
    Clin Toxicol (Phila); 2022 Mar; 60(3):356-361. PubMed ID: 34406096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of major morbidity and death in older adults with suicidal intent: a cross-sectional analysis from the National Poison Data System, 2000-2009.
    Cobaugh DJ; Miller MJ; Pham TT; Krenzelok EP
    J Am Geriatr Soc; 2015 Mar; 63(3):501-7. PubMed ID: 25735433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report.
    Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC
    Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing severity of medical outcomes and associated substances in cases reported to United States poison centers.
    Farah R; Cole RJ; Holstege CP
    Clin Toxicol (Phila); 2024 Apr; 62(4):248-255. PubMed ID: 38634480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine prescribing practices and exposures reported to a poison center--Utah, 2002-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Dec; 61(49):997-1001. PubMed ID: 23235296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical outcomes associated with nonmedical use of methadone and buprenorphine.
    Lee S; Klein-Schwartz W; Welsh C; Doyon S
    J Emerg Med; 2013 Aug; 45(2):199-205. PubMed ID: 23669129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.